跳至主要内容
临床试验/NCT01601639
NCT01601639已完成3 期

Endoscopic Band Ligation vs Argon Plasma Coagulation for the Treatment of Gastric Antral Vascular Ectasia: a Randomized Clinical Trial

University of Alberta2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2012年9月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
30
试验地点
2
主要终点
New event of upper gastrointestinal bleeding

研究概览

简要总结

The investigators goal is to compare the standard argon plasma coagulation (APC) treatment with endoscopic band ligation (EBL) in patients with Gastric Antral Vascular Ectasia.

详细描述

Gastric antral vascular ectasia (GAVE) is a vascular structural malformation in the stomach that can lead to active or chronic intermittent gastrointestinal bleeding or chronic iron-deficiency anemia.

The current standard endoscopic treatment is with APC. There have been multiple reports and case series in the literature about successful treatment with EBL for GAVE, even in cases where APC was unsuccessful for treatment of GAVE. Our goal is to compare the standard APC treatment with EBL in patients with Gastric Antral Vascular Ectasia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Consecutive patients with GAVE identified at endoscopic examination, patients may have active GI bleeding, chronic anemia or drop in hemoglobin levels.

排除标准

  • Patients with previous endoscopic treatment for GAVE within the last 3 months, patients with GAVE without chronic anemia or active bleeding, patients in whom another possible source of GI bleeding is found

结局指标

主要结局

New event of upper gastrointestinal bleeding

时间窗: one year

Number of new episodes of upper gastrointestinal bleeding characterized by melena, hematemesis or quick and significant drop in hemoglobin levels will be documented after the first session of therapy.The hemoglobin level will be recorded before the procedure and 4,8,and 12 weeks after the first endoscopic treatment for GAVE to document changes from baseline. Patients showing stabilization of hemoglobin levels (no significant drop or improvement in levels) without other signs of gastrointestinal bleeding will be considered as treatment success.

次要结局

  • Number of sessions required for GAVE eradication(one year)
  • Ferritin(one year)
  • Total procedure time(one year)
  • Blood transfusion requirements(one year)
  • Iron studies(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sergio Zepeda

Assistant Professor, Division of Gastroenterology

University of Alberta

研究点 (2)

Loading locations...

相似试验